JP2001525816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001525816A5 JP2001525816A5 JP1998548911A JP54891198A JP2001525816A5 JP 2001525816 A5 JP2001525816 A5 JP 2001525816A5 JP 1998548911 A JP1998548911 A JP 1998548911A JP 54891198 A JP54891198 A JP 54891198A JP 2001525816 A5 JP2001525816 A5 JP 2001525816A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85488197A | 1997-05-12 | 1997-05-12 | |
| US08/854,881 | 1997-05-12 | ||
| PCT/GB1998/001343 WO1998051344A1 (en) | 1997-05-12 | 1998-05-12 | Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001525816A JP2001525816A (ja) | 2001-12-11 |
| JP2001525816A5 true JP2001525816A5 (enExample) | 2005-12-02 |
Family
ID=25319772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54891198A Withdrawn JP2001525816A (ja) | 1997-05-12 | 1998-05-12 | 治療における腫瘍壊死因子アルファおよび血管内皮成長因子の抑制 |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP0980258A1 (enExample) |
| JP (1) | JP2001525816A (enExample) |
| AU (1) | AU7345798A (enExample) |
| CA (1) | CA2290021A1 (enExample) |
| HK (1) | HK1044887A1 (enExample) |
| WO (1) | WO1998051344A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0486526B2 (en) | 1989-08-07 | 2001-03-07 | Peptech Limited | Tumour necrosis factor binding ligands |
| US20030225254A1 (en) | 1989-08-07 | 2003-12-04 | Rathjen Deborah Ann | Tumour necrosis factor binding ligands |
| US7192584B2 (en) | 1991-03-18 | 2007-03-20 | Centocor, Inc. | Methods of treating psoriasis with anti-TNF antibodies |
| JP2002500883A (ja) | 1998-01-22 | 2002-01-15 | ビー・テイー・ジー・インターナシヨナル・リミテツド | サイトカイン産生の抑制 |
| PT1159003E (pt) * | 1999-03-02 | 2011-02-22 | Centocor Inc | Anti-tnf alfa na terapêutica da asma resistente a esteróides |
| US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
| US7101974B2 (en) | 2000-03-02 | 2006-09-05 | Xencor | TNF-αvariants |
| US7662367B2 (en) | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
| US7687461B2 (en) | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
| WO2001064889A2 (en) * | 2000-03-02 | 2001-09-07 | Xencor | Tnf-alpha variants for the treatment of tnf-alpha related disorders |
| US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
| US7244823B2 (en) | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
| US7056695B2 (en) | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
| US9028822B2 (en) | 2002-06-28 | 2015-05-12 | Domantis Limited | Antagonists against TNFR1 and methods of use therefor |
| US20040131614A1 (en) * | 2002-07-19 | 2004-07-08 | Abbott Biotechnology Ltd. | Treatment of pulmonary disorders using TNFalpha inhibitor |
| MXPA05003889A (es) | 2002-10-15 | 2005-06-22 | Celgene Corp | Farmacos inhibidores de citosina selectiva para tratar sindrome mielodisplastico. |
| US7101978B2 (en) | 2003-01-08 | 2006-09-05 | Applied Molecular Evolution | TNF-α binding molecules |
| WO2005021554A1 (en) | 2003-08-29 | 2005-03-10 | Pfizer Inc. | Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents |
| WO2005041877A2 (en) * | 2003-10-29 | 2005-05-12 | Children's Medical Center Corporation | Method of inhibiting rejection following organ transplantation |
| AP2006003619A0 (en) | 2003-12-23 | 2006-06-30 | Pfizer | Novel quinoline derivatives |
| US7435799B2 (en) | 2004-01-08 | 2008-10-14 | Applied Molecular Evolution | TNF-α binding molecules |
| JP5757495B2 (ja) | 2005-05-16 | 2015-07-29 | アッヴィ バイオテクノロジー リミテッド | びらん性多発性関節炎の治療のためのｔｎｆ阻害剤の使用 |
| JP2008120722A (ja) * | 2006-11-10 | 2008-05-29 | Benesis Corp | 生物由来製品の偽薬 |
| US8579865B2 (en) * | 2009-03-20 | 2013-11-12 | Antares Pharma, Inc. | Hazardous agent injection system |
| JP2014518758A (ja) | 2011-05-06 | 2014-08-07 | バイオ−ラッド ラボラトリーズ インコーポレーティッド | 迅速な温度変化のためのベイパーチャンバーを備えたサーマルサイクラー |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE07012626T1 (de) * | 1991-03-18 | 2010-01-21 | New York University | Monoklonale und chimäre Antikörper gegen humanen Tumornekrosefaktor |
| NZ256293A (en) * | 1992-09-15 | 1997-06-24 | Immunex Corp | Method of treating tumour necrosis factor - mediated inflammation by use of tnf antagonist |
| US6270766B1 (en) * | 1992-10-08 | 2001-08-07 | The Kennedy Institute Of Rheumatology | Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease |
| KR100335584B1 (ko) * | 1992-10-28 | 2002-11-29 | 제넨테크, 인코포레이티드 | 혈관내피세포성장인자에대한길항제 |
| US7608262B2 (en) * | 1996-02-16 | 2009-10-27 | The Kennedy Institute Of Rheumatology | Methods of preventing or treating thrombosis with tumor necrosis factor antagonists |
-
1998
- 1998-05-12 EP EP98920669A patent/EP0980258A1/en not_active Ceased
- 1998-05-12 JP JP54891198A patent/JP2001525816A/ja not_active Withdrawn
- 1998-05-12 WO PCT/GB1998/001343 patent/WO1998051344A1/en not_active Ceased
- 1998-05-12 EP EP01117491A patent/EP1170017A1/en not_active Withdrawn
- 1998-05-12 AU AU73457/98A patent/AU7345798A/en not_active Abandoned
- 1998-05-12 CA CA002290021A patent/CA2290021A1/en not_active Abandoned
-
2002
- 2002-07-09 HK HK02105101.3A patent/HK1044887A1/en unknown